AllianceBernstein
MYOV

AllianceBernstein’s Myovant Sciences Ltd. MYOV Stock Holding History

AllianceBernstein’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-182,389
Closed -$2.56M – 3228
2020
Q3 		$2.56M Buy
182,389
+49,307
+37% +$917K ﹤0.01% 1711
2020
Q2 		$2.74M Buy
+133,082
New +$1.81M ﹤0.01% 1667

Other funds holding MYOV

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

AllianceBernstein's MYOV Position: Q4 2020 in Review

AllianceBernstein sold out of Myovant Sciences Ltd. (MYOV) in Q4 2020, closing a stake of 182,389 shares — an estimated $2.56M sold.

AllianceBernstein first reported a position in MYOV in Q2 2020 and held it in 2 quarters. The position peaked at $2.74M in Q2 2020. 105 funds tracked by Wall St. Rank hold MYOV as of Q4 2020.

  • AllianceBernstein reported no remaining Myovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • AllianceBernstein sold 182,389 Myovant Sciences Ltd. shares in Q4 2020, an estimated $2.56M.
  • AllianceBernstein first reported a position in Myovant Sciences Ltd. in Q2 2020 and held it in 2 quarters.
  • AllianceBernstein's Myovant Sciences Ltd. position peaked at $2.74M in Q2 2020.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2020.

Based on AllianceBernstein's 13F filing for Q4 2020, filed 8 Feb 2021.